BriaCell Therapeutics Corp. (BCTX) Net Equity Issued and Repurchased (2024 - 2025)
BriaCell Therapeutics (BCTX) posted Net Equity Issued and Repurchased of $13.6 million for Q3 2025, down 7.87% sequentially from $14.7 million in Q2 2025.
BriaCell Therapeutics Corp. (BCTX) Net Equity Issued and Repurchased (2024 - 2025) Analysis & Trends
BriaCell Therapeutics has reported Net Equity Issued and Repurchased for 2 years, with the latest figure at $13.6 million in Q3 2025.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $13.6 million in Q3 2025, while the trailing twelve-month figure through Apr 2026 was $33.0 million (changed N/A YoY) and the FY2025 annual result came in at $44.6 million, up 909.91% from the prior year.
- Net Equity Issued and Repurchased slipped to $13.6 million in Q3 2025 per BCTX's latest filing, from $14.7 million in the prior quarter.
- Over five years, Net Equity Issued and Repurchased peaked at $14.7 million in Q2 2025 and troughed at $4.7 million in Q1 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | 13.56 Mn |
| Jul 31, 2025 | 13.56 Mn |
| Apr 30, 2025 | 14.71 Mn |
| Apr 30, 2025 | 14.71 Mn |
| Jan 31, 2025 | 4.69 Mn |
| Jan 31, 2025 | 4.69 Mn |
| Oct 31, 2024 | 11.67 Mn |
| Oct 31, 2024 | 11.67 Mn |